The heptadecapeptide, orphanin FQ/nociceptin (OFQ/N), binds with high affin
ity to the ORL-1/KOR-3 opioid receptor clone. yet binds poorly with traditi
onal opioid receptors. OFQ/N has a complex functional profile with relation
to nociceptive processing, displaying pro-nociceptive properties in some s
tudies, acting as an inhibitor of stress-induced analgesia in others, yet p
roducing both spinal and supraspinal antinociceptive actions in other studi
es. Among the intracerebral sites at which OFQ/N might produce one or more
of these actions is the amygdala which has been intimately implicated in bo
th antinociceptive and stress-related responses. Therefore, the present stu
dy assessed whether microinjections into the amygdala of equimolar doses of
OFQ/N1-17 or its shorter-chained active fragments, OFQ/N1-11 or OFQ/N1-7,
would produce analgesia as measured by either reactivity to high-intensity
radiant heat or reactivity to electric shock, and produce hyperalgesia as m
easured by reactivity to lower-intensity radiant heat. OFQ/N1-17 in the amy
gdala produced a dose-dependent and time-dependent increase in high-intensi
ty tail-flick latencies with maximal effects observed at a dose range of 0.
75-3 nmol, and lesser effects at lower (0.015-0.15 nmol) and higher (5.5-30
nmol) doses. Both OFQ/N1-11 and OFQ/N1-7 in the amygdala displayed lower m
agnitudes of analgesia than OFQ/N1-17 on this measure, with OFQ/N1-11 displ
aying maximal effects at higher (15-30 nmol) doses and OFQ/N1-7 displaying
maximal effects at lower (0.15-1.5 nmol) doses. In contrast to traditional
mu and kappa opioids and beta -endorphin, none of the OFQ/N fragments in th
e amygdala exhibited any analgesic responses on the jump test. Finally, usi
ng a low-intensity radiant heat assay capable of detecting hyperalgesic res
ponses, each of the OFQ/N fragments in the amygdala increased tail-Rick lat
encies on this measure. Therefore, OFQ/N fragments appear to exert only ana
lgesic responses in the amygdala with quantitative and qualitative differen
ces relative to traditional opioid agonists. (C) 2001 Published by Elsevier
Science B.V.